Overview

Multiple-Ascending-Dose Study to Evaluate the Safety of Propoxyphene Napsylate In Healthy Adult Subjects

Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the daily maximum tolerated dose of propoxyphene napsylate in healthy subjects.
Phase:
Phase 4
Details
Lead Sponsor:
Xanodyne Pharmaceuticals
Treatments:
Dextropropoxyphene
Levopropoxyphene